Search icon

Tedor Pharma Inc.

Company Details

Name: Tedor Pharma Inc.
Jurisdiction: Rhode Island
Entity type: Foreign Corporation
Status: Activ
Date of Organization in Rhode Island: 29 Oct 2002 (23 years ago)
Identification Number: 000127758
ZIP code: 02864
County: Providence County
Place of Formation: DELAWARE
Purpose: TO DEVELOP AND MANUFACTURE OF PHARMACEUTICAL PRODUCTS FOR RX, COMMERCIAL, NUTRACEUTICAL, AND CLINICAL CLIENTS
Principal Address: Google Maps Logo 400 HIGHLAND CORPORATE DR, CUMBERLAND, RI, 02864, USA

Contact Details

Phone +1 401-405-3000

Industry & Business Activity

NAICS

325412 Pharmaceutical Preparation Manufacturing

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Learn more at the U.S. Census Bureau

Agent

Name Role Address
WILLIAM KAZIMIER Agent 400 HIGHLAND CORPORATE DRIVE, CUMBERLAND, RI, 02864, USA

PRESIDENT

Name Role Address
LAURA IORIO PRESIDENT C/O TEDOR PHARMA 400 HIGHLAND CORPORATE DRIVE CUMBERLAND, RI 02864 USA

TREASURER

Name Role Address
LAURA IORIO TREASURER C/O TEDOR PHARMA 400 HIGHLAND CORPORATE DRIVE CUMBERLAND, RI 02864 USA

SECRETARY

Name Role Address
JOHN CHU SECRETARY C/O TEDOR PHARMA 400 HIGHLAND CORPORATE DR CUMBERLAND, RI 02864 USA

DIRECTOR

Name Role Address
LAURA IORIO DIRECTOR C/O TEDOR PHARMA 400 HIGHLAND CORPORATE DR CUMBERLAND, RI 02864 USA

Central Index Key

A CIK (Central Index Key) number is a unique identifier assigned by the U.S. Securities and Exchange Commission (SEC) to companies that: Are publicly traded on U.S. stock exchanges, File reports with the SEC.

Note: Having a CIK number indicates that: The company is registered with the SEC, Files regular financial reports (like 10-K, 10-Q), Must comply with federal securities laws and regulations, Has public shareholders, Makes financial information publicly available through SEC's EDGAR database.

CIK number:
0001211226
Phone:
617-732-2212

Latest Filings

Form type:
REGDEX
File number:
021-50851
Filing date:
2002-12-09
File:

Form 5500 Series

Employer Identification Number (EIN):
043554756
Plan Year:
2023
Number Of Participants:
40
Sponsors Telephone Number:
Plan Year:
2022
Number Of Participants:
39
Sponsors Telephone Number:
Plan Year:
2021
Number Of Participants:
49
Sponsors Telephone Number:
Plan Year:
2020
Number Of Participants:
63
Sponsors Telephone Number:
Plan Year:
2019
Number Of Participants:
58
Sponsors Telephone Number:

Licenses

License No License Type Status Date Issued Expiration Date
WSL00175 Drug Wholesaler-In State Active 2023-05-05 2025-09-30
MNF00068 Drug Manufacturer-In State Active 2003-01-13 2025-09-30

Filings

Number Name File Date
202458756890 Statement of Change of Registered/Resident Agent 2024-08-13
202458756340 Annual Report 2024-08-13
202457156240 Revocation Notice For Failure to File An Annual Report 2024-06-25
202340086250 Annual Report 2023-08-02
202338060390 Revocation Notice For Failure to File An Annual Report 2023-06-19

Uniform Commercial Code

The Uniform Commercial Code (UCC) is a comprehensive set of laws governing all commercial transactions in the United States.

A UCC filing is a public notice of a secured transaction. A financing statement indicates a commercial agreement between a debtor and a secured party.

Uniform Commercial Code Summary

Type:
UCC-1 Standard
UCC Filing Number:
Filing Date:
2024-08-21
Action:
InitialFiling

Parties

Party Name:
Tedor Pharma Inc.
Party Role:
Debtor(s)
Party Role:
Secured Parties

Uniform Commercial Code Summary

Type:
UCC-1 Standard
UCC Filing Number:
Filing Date:
2024-08-20
Action:
InitialFiling

Parties

Party Name:
Tedor Pharma Inc.
Party Role:
Debtor(s)
Party Role:
Secured Parties

USAspending Awards / Financial Assistance

Date:
2021-02-10
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
949360.20
Total Face Value Of Loan:
949360.20
Date:
2020-07-13
Awarding Agency Name:
Small Business Administration
Transaction Description:
ECONOMIC INJURY DISASTER GRANT
Obligated Amount:
10000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-04-28
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
1023057.00
Total Face Value Of Loan:
1023057.00

Trademarks

Serial Number:
77105697
Mark:
POLYDOSE
Status:
Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Service Mark
Application Filing Date:
2007-02-12
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
POLYDOSE

Goods And Services

For:
Scientific services, namely, scientific research and development, chemical research and development, and pharmaceutical research and development services relating to chemical and pharmaceutical preparations
International Classes:
042 - Primary Class
Class Status:
ACTIVE
Serial Number:
76270929
Mark:
TEDOR PHARMA
Status:
Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark
Application Filing Date:
2001-06-12
Mark Drawing Type:
1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Literal Elements:
TEDOR PHARMA

Goods And Services

For:
Pharmaceutical products for use in treating patients suffering from pulmonary disorders such as asthma, bile-related disorders and conditions, dermatological conditions such as acne, and obesity
First Use:
2004-11-02
International Classes:
005 - Primary Class
Class Status:
SECTION 8 - CANCELLED
Serial Number:
76270612
Mark:
T
Status:
Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark
Application Filing Date:
2001-06-12
Mark Drawing Type:
5 - AN ILLUSTRATION DRAWING WITH WORD(S)/LETTER(S)/NUMBER(S) IN STYLIZED FORM
Mark Literal Elements:
T

Goods And Services

For:
Pharmaceutical products for use in treating patients suffering from pulmonary disorders such as asthma, bile-related disorders and conditions, dermatological conditions such as acne, and obesity
First Use:
2004-11-02
International Classes:
005 - Primary Class
Class Status:
ACTIVE

Paycheck Protection Program

Date Approved:
2020-04-28
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Initial Approval Amount:
1023057
Current Approval Amount:
1023057
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
1033600.17
Date Approved:
2021-02-10
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Initial Approval Amount:
949360.2
Current Approval Amount:
949360.2
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Female Owned
Veteran:
Unanswered
Forgiveness Amount:
961543.66

Date of last update: 21 May 2025

Sources: Rhode Island Department of State